Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment

Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment

Background. We examined (1) patient characteristics and disease-modifying drug (DMD) exposure in late-onset (LOMS, ≥50 years at symptom onset) versus adult-onset (AOMS, 18–<50 years) MS and (2) the association between interferon-beta (IFNβ) and disability progression in older relapsing-onset MS a...

Full description

Bibliographic Details
Main Authors: Afsaneh Shirani, Yinshan Zhao, John Petkau, Paul Gustafson, Mohammad Ehsanul Karim, Charity Evans, Elaine Kingwell, Mia L. van der Kop, Joel Oger, Helen Tremlett
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2015/451912

Internet

http://dx.doi.org/10.1155/2015/451912

Similar Items